-
Soda pop study with the usual self-reporting bias food questionnaires links to risk of developing fatty liver disease. Not great to drink the stuff so limiting use is a healthful choice for many reasons but study itself cannot demonstrate causality.
Medical Mythbusting Commentary for February 13, 2026 Source:This Everyday Nonalcoholic Drink Could Be Linked to Serious Liver Risk, Researchers Say Reference:Soft drink consumption and increased risk of nonalcoholic fatty liver disease: Results from the health workers cohort study Referenced Study: “Soft drink consumption and increased risk of nonalcoholic fatty liver disease: Results from the health…
tagged:
-
Do I give the study that claims in just 7 minutes each day you could extend your life buy a year any credence? Absolutely not.
Medical Mythbusting Commentary for February 12, 2026 Source:In Just 7 Minutes Each Day, You Could Extend Your Life by a Year—Scientists Reveal How Reference:Minimum combined sleep, physical activity, and nutrition variations associated with lifeSPAN and healthSPAN improvements: a population cohort study Study Background: Cohort study from UK Biobank with 59,078 adults aged 40-69. Measured sleep…
-
Babies given peanuts, fish, eggs early less likely to become allergic, study affirms
Medical Mythbusting Commentary for February 11, 2026 Source:Babies given peanuts, fish, eggs early less likely to become allergic, study affirms Reference:Risk Factors for the Development of Food Allergy in Infants and Children
tagged:
-
‘Night owls’ may have worse heart health — but why? Well, they smoked more, had poorer sleep, were less active, and had poorer dietary habits. So it may not be being a night owl that is the causative factor but what we already know to be harmful to health outcomes.
Medical Mythbusting Commentary for February 10, 2026 Source:‘Night owls’ may have worse heart health — but why? Reference:Chronotype, Life’s Essential 8, and Risk of Cardiovascular Disease: A Prospective Cohort Study in UK Biobank
tagged:
-
Oral version of injectable cholesterol-lowering medication completes phase 3 trial with noted reductions in LDL-cholesterol as well as lipoproteins.
Medical Mythbusting Commentary for February 9, 2026 Source:Experimental cholesterol-lowering pill may offer new option for millions Reference:A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
tagged:
-
House Calls, #1001, February 8, 2026: Say Goodbye to Hollywood
New insights into the mechanism that contributes to Parkinson’s Disease Why some people lose hair when using GLP-1 medications like Ozempic Your Calls and Comments: Playlist 1st segment Intro: Mad World – Tears for fears Outro: Those Were The Days – Mary Hopkin 2nd segment Intro: Go Your Own Way – Fleetwood Mac Outro: It’s…
tagged:
-
Phase 1 study shows that nasal spray delivery of anti-flu antibodies is safe and effective however duration of action is only three hours before antibodies degrade.
Medical Mythbusting Commentary for February 6, 2026 Source:Breakthrough nasal spray found to protect against all forms of flu Reference:Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114
tagged:
-
Report urges Canadians to focus on health basics as 80% of premature heart disease and stroke preventable
Medical Mythbusting Commentary for February 5, 2026 Source:Report urges Canadians to focus on health basics as 80% of premature heart disease and stroke preventable Reference:Heart & Stroke report: New data provides big picture of heart and brain risk factors
tagged:
-
Blood of Exceptionally Long-Lived People Reveals Crucial Differences. However, there is a long way to go before this translates into clinical application.
Medical Mythbusting Commentary for February 4, 2026 Source:Blood of Exceptionally Long-Lived People Reveals Crucial Differences Reference:The multiomics blueprint of the individual with the most extreme lifespanMetabolomic Signatures of Extreme Old Age: Findings from the New England Centenarian Study
tagged: